Breadcrumb AMCP.org Policy & Advocacy Letters, Statements & Analysis AMCP Submits Comments on Hawaii HB 254 Concerning Biosimilars AMCP Submits Comments on Hawaii HB 254 Concerning Biosimilars 4/29/16 Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page AMCP Comments RE - H.B. 254.pdf Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page